Pınar ÇAKMAK, Perran MOROY, Nuri DANIŞMAN, Leyla MOLLAMAHMUTOĞLU, Ayhan SUCAK, Tamer MUNGAN

Insulin-like growth factor binding protein-I; a rapid detection of amniotic fluid leakage after amniocentesis

The aim of this study was to assess the diagnostic value of vaginal insulin-like growth factor binding protein-1 (IGFBP-I) in the detection of amniotic fluid leakage after amniocentesis. It includes 58 healthy pregnant women who successfully underwent amniocentesis at 15-20 weeks of gestation. After amniocentesis patients were evaluated for amniotic fluid leakage at 60 min, 48 h, and 6 weeks after the procedure with speculum examination, nitrazine paper test and microscopic evidence of ferning, and were grouped into Group I (at least 2 positive tests) and Group II (others) according to the first evaluation. All patients tested for vaginal IGFBP-I. A total of 1.1% (7/58) of patients met the Group I criteria. Vaginal bleeding and contraction occurrence was nonsignificantly higher in Group I. One false positive and one false negative result were obtained from IGFBP-I testing. The sensitivity of this test was 85%, specificity was 98%, positive predictive value (PPV) was 85% and negative predictive value (NPV) was 98%. After 48 h the sensitivity of this test was 75%, specificity was 98%, PPV was 75% and NPV was 98%. Results at the 6th week were similar to those at 48 h. In conclusion the detection of vaginal IGFBP-I is highly predictive for amniotic fluid leakage especially in clinically doubtful cases.

PDF

___

1. Tabor A, Madsen M, Obel EB et al. Randomized controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1: 1287-1291, 1986.
2. Rutanen EM, Pekonen F, Karakainen T. Measurement of insulin-like growth-factor binding protein-1 in cervical-vaginal secretions: comparison with the ROM-check membrane immunoassay in the diagnosis of ruptured fetal membranes. Clin Chim Acta 214: 73-81, 1993.
3. Lockwood CJ, Wein R, Chien D et al. Fetal membrane rupture is associated with the presence of insulin-like growth factor-binding protein-1 in vaginal secretions. Am J Obst Gyn 171: 146-150, 1994.
4. Rutanen EM, Karkkainen T, Lehtovirta J et al. Evaluation of a rapid strip test for insulin-like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Clin Chim Acta 253: 91-101, 1996.
5. Esim E, Turan C, Ünal O et al. Diagnosis of rupture of membranes by identification of P-HCG in vaginal washing fluid. Eur J Obstet Gyneco Reprod Bio 77: 295-297, 2003.
6. Darj E, Lyrenas S. Insulin-like growth factor binding protein-1: a quick way to detect amniotic fluid. Acta Obstet Gynecol Scand. 77: 295-297, 1998.
7. Jeurgensx-Borst AJCM, Bekkers RLM, Sporken JMJ et al. Use of insulin growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Eur J Obstet Gyneco Reprod Bio 102: 11-14,2002.
8. Bhatia S, Faessen GH, Carland G et al. A longitudinal analysis of maternal serum insulin-like growth factor I (IGF-1) and total and nonphosphorylated IGF-binding protein-1 in human pregnancies complicated by intrauterine growth restration. J Clin Endocrinol Metab 87: 1864-1870, 2002.
9. Wang HS, Perry LA, Kanisius J et al. Purification and assay of insulin-like growth factor binding protein-1: measurement of circulating levels throughout pregnancy. Journal of Endocrinology 128: 161-168, 1991.
10. Okajima T, Iwashita M, Takeda Y et al. Inhibitory effects of insulin-like growth factor (IGF) binding protein -1 and 3 on IGF-activated glucose consumption in mouse BALB/c 3T3 fibroblasts. Journal of Endocrinology 136: 457-470, 1993.
11. Ohnishi Y, Yamashiro C, Yanagihara T et al. Hepatocyte growth factor concentration in the early second-trimester amniotic fluid does not predict fetal growth at birth. Human Reproduction and Embriology 14: 2625-2628, 1999.
12. Javad Khosravi M, Diamandi A, Mistry J. Immunoassay of insulin-like growth factor binding protein-1. Clin Chim. 43: 523-532, 1997.